Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.39 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.39 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.39 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.39 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.39 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3987325 | 0.98 | KMT2A (0.41) | KMT2ATSHRHSD17B10KDM4EHPGD | |
| SCHEMBL28664851 | 0.85 | TRPV6 (0.44) | TSHRCA4CA6CA5ACA7 | |
| SCHEMBL28291707 | 0.85 | MGLL (0.51) | KMT2AKDM4EEGFR | |
| SCHEMBL5778129 | 0.82 | KMT2A (0.44) | KMT2ATSHRHSD17B10KDM4EHPGD | |
| SCHEMBL6590484 | 0.80 | HSD17B10 (0.42) | HSD17B10ENPP2ALDH1A1RAB9ASMN1; SMN2 | |
| Biphenyl SCHEMBL28688628 | 0.80 | MGLL (0.43) | KMT2ATSHRHSD17B10KDM4EHPGD | |
| SCHEMBL4763196 | 0.79 | TSHR (0.38) | KMT2ATSHRHSD17B10HPGDCA4 | |
| SCHEMBL1237692 | 0.79 | TSHR (0.44) | KMT2ATSHRHSD17B10ALDH1A1MAPT | |
| SCHEMBL18424371 | 0.79 | CYP2C19 (0.39) | KMT2ATSHRHSD17B10CA4CA6 | |
| SCHEMBL651370 | 0.79 | ORAI1 (0.42) | TSHRHSD17B10KDM4EHPGDCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307822-A | Production process of environment-friendly laminating material | 广东美士达药包材料股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-117946029-A | Organic molecule capable of emitting red light as well as preparation method and application thereof | 中国科学院福建物质结构研究所 | 2024-04-30 | — | — | CN | claimed |
| CN-117534681-A | Preparation and application of aromatic ester electrochromic material with spirodipropyl dioxythiophene as core | 南京林业大学 | 2024-02-09 | — | — | CN | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| CN-115433364-A | Hydrogen bond organic molecular framework material HOF-NBDA and preparation method and application thereof | 中国科学院福建物质结构研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-111004149-B | Method for preparing polyfluorobenzonitrile by catalytic fluorination of polychlorinated benzonitrile | 大连奇凯医药科技有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-113354828-A | Preparation and application of novel stable metal organic framework material | 沈阳大学 | 2021-09-07 | — | — | CN | claimed |
| CN-112898583-A | Preparation method and application of metal organic framework material | 北京化工大学 | 2021-06-04 | — | — | CN | claimed |
| CN-112812320-A | Preparation of nitrogen-substituted metal organic framework material and high-pressure methane storage application thereof | 沈阳大学 | 2021-05-18 | — | — | CN | claimed |
| EP-2729184-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | Institut National de la Recherche Scientifique (CA) | 2014-05-14 | — | — | EP | claimed |
| WO-2012149644-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2012-11-08 | — | — | WO | claimed |
| US-12545640-B2 | Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof | SANOFI (FR) | 2026-02-10 | — | — | US | disclosed |
| CN-119751461-A | PKMYT1 inhibitor and preparation method and application thereof | 中国药科大学 | 2025-04-04 | — | — | CN | disclosed |
| WO-2025045826-A1 | COMPOUNDS FOR ACTIVATION OF FGFR1 SIGNALING | THE CULTIVATED B. GMBH (DE) | 2025-03-06 | — | — | WO | disclosed |
| US-20240237529-A1 | NOVEL COMPOUND, AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| WO-2005123680-A1 | SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-12-29 | — | — | WO | disclosed |
| WO-2005097740-A1 | HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2005-10-20 | — | — | WO | disclosed |
| WO-2005042488-A1 | PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-12 | — | — | WO | disclosed |
| EP-1503992-A1 | PYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE4 INHIBITORS | Almirall Prodesfarma, S.A. (ES) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003097613-A1 | PYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE4 INHIBITORS | ALMIRALL PRODESFARMA SA (ES) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545640-B2 | Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof | ESRRA, GPER1, FSHR | KMT2A 3398/4885TSHR 34/4885HSD17B10 211/4885 |
| US-20240237529-A1 | NOVEL COMPOUND, AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING SAME | CRY1, NCS1, CYP4X1 | KMT2A 968/4885TSHR 3853/4885HSD17B10 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.